These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 34013273)

  • 1. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
    Joyce MG; Chen WH; Sankhala RS; Hajduczki A; Thomas PV; Choe M; Chang W; Peterson CE; Martinez E; Morrison EB; Smith C; Ahmed A; Wieczorek L; Anderson A; Chen RE; Case JB; Li Y; Oertel T; Rosado L; Ganesh A; Whalen C; Carmen JM; Mendez-Rivera L; Karch C; Gohain N; Villar Z; McCurdy D; Beck Z; Kim J; Shrivastava S; Jobe O; Dussupt V; Molnar S; Tran U; Kannadka CB; Zemil M; Khanh H; Wu W; Cole MA; Duso DK; Kummer LW; Lang TJ; Muncil SE; Currier JR; Krebs SJ; Polonis VR; Rajan S; McTamney PM; Esser MT; Reiley WW; Rolland M; de Val N; Diamond MS; Gromowski GD; Matyas GR; Rao M; Michael NL; Modjarrad K
    bioRxiv; 2021 May; ():. PubMed ID: 34013273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
    Joyce MG; Chen WH; Sankhala RS; Hajduczki A; Thomas PV; Choe M; Martinez EJ; Chang WC; Peterson CE; Morrison EB; Smith C; Chen RE; Ahmed A; Wieczorek L; Anderson A; Case JB; Li Y; Oertel T; Rosado L; Ganesh A; Whalen C; Carmen JM; Mendez-Rivera L; Karch CP; Gohain N; Villar Z; McCurdy D; Beck Z; Kim J; Shrivastava S; Jobe O; Dussupt V; Molnar S; Tran U; Kannadka CB; Soman S; Kuklis C; Zemil M; Khanh H; Wu W; Cole MA; Duso DK; Kummer LW; Lang TJ; Muncil SE; Currier JR; Krebs SJ; Polonis VR; Rajan S; McTamney PM; Esser MT; Reiley WW; Rolland M; de Val N; Diamond MS; Gromowski GD; Matyas GR; Rao M; Michael NL; Modjarrad K
    Cell Rep; 2021 Dec; 37(12):110143. PubMed ID: 34919799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
    King HAD; Gordon Joyce M; Naouar IE; Ahmed A; Cincotta CM; Subra C; Peachman KK; Hack HH; Chen RE; Thomas PV; Chen WH; Sankhala RS; Hajduczki A; Martinez EJ; Peterson CE; Chang WC; Choe M; Smith C; Headley JA; Elyard HA; Cook A; Anderson A; Wuertz KM; Dong M; Swafford I; Case JB; Currier JR; Lal KG; Amare MF; Dussupt V; Molnar S; Daye SP; Zeng X; Barkei EK; Alfson K; Staples HM; Carrion R; Krebs SJ; Paquin-Proulx D; Karasavvas N; Polonis VR; Jagodzinski LL; Vasan S; Scott PT; Huang Y; Nair MS; Ho DD; de Val N; Diamond MS; Lewis MG; Rao M; Matyas GR; Gromowski GD; Peel SA; Michael NL; Modjarrad K; Bolton DL
    bioRxiv; 2021 Apr; ():. PubMed ID: 33851155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity.
    Chen WH; Hajduczki A; Martinez EJ; Bai H; Matz H; Hill TM; Lewitus E; Chang WC; Dawit L; Peterson CE; Rees PA; Ajayi AB; Golub ES; Swafford I; Dussupt V; David S; Mayer SV; Soman S; Kuklis C; Corbitt C; King J; Choe M; Sankhala RS; Thomas PV; Zemil M; Wieczorek L; Hart T; Duso D; Kummer L; Yan L; Sterling SL; Laing ED; Broder CC; Williams JK; Davidson E; Doranz BJ; Krebs SJ; Polonis VR; Paquin-Proulx D; Rolland M; Reiley WW; Gromowski GD; Modjarrad K; Dooley H; Joyce MG
    Nat Commun; 2023 Feb; 14(1):580. PubMed ID: 36737435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
    Wuertz KM; Barkei EK; Chen WH; Martinez EJ; Lakhal-Naouar I; Jagodzinski LL; Paquin-Proulx D; Gromowski GD; Swafford I; Ganesh A; Dong M; Zeng X; Thomas PV; Sankhala RS; Hajduczki A; Peterson CE; Kuklis C; Soman S; Wieczorek L; Zemil M; Anderson A; Darden J; Hernandez H; Grove H; Dussupt V; Hack H; de la Barrera R; Zarling S; Wood JF; Froude JW; Gagne M; Henry AR; Mokhtari EB; Mudvari P; Krebs SJ; Pekosz AS; Currier JR; Kar S; Porto M; Winn A; Radzyminski K; Lewis MG; Vasan S; Suthar M; Polonis VR; Matyas GR; Boritz EA; Douek DC; Seder RA; Daye SP; Rao M; Peel SA; Joyce MG; Bolton DL; Michael NL; Modjarrad K
    NPJ Vaccines; 2021 Oct; 6(1):129. PubMed ID: 34711815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
    Sankhala RS; Lal KG; Jensen JL; Dussupt V; Mendez-Rivera L; Bai H; Wieczorek L; Mayer SV; Zemil M; Wagner DA; Townsley SM; Hajduczki A; Chang WC; Chen WH; Donofrio GC; Jian N; King HAD; Lorang CG; Martinez EJ; Rees PA; Peterson CE; Schmidt F; Hart TJ; Duso DK; Kummer LW; Casey SP; Williams JK; Kannan S; Slike BM; Smith L; Swafford I; Thomas PV; Tran U; Currier JR; Bolton DL; Davidson E; Doranz BJ; Hatziioannou T; Bieniasz PD; Paquin-Proulx D; Reiley WW; Rolland M; Sullivan NJ; Vasan S; Collins ND; Modjarrad K; Gromowski GD; Polonis VR; Michael NL; Krebs SJ; Joyce MG
    Nat Commun; 2024 Jan; 15(1):200. PubMed ID: 38172512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters.
    Wuertz KM; Barkei EK; Chen WH; Martinez EJ; Lakhal-Naouar I; Jagodzinski LL; Paquin-Proulx D; Gromowski GD; Swafford I; Ganesh A; Dong M; Zeng X; Thomas PV; Sankhala RS; Hajduczki A; Peterson CE; Kuklis C; Soman S; Wieczorek L; Zemil M; Anderson A; Darden J; Hernandez H; Grove H; Dussupt V; Hack H; de la Barrera R; Zarling S; Wood JF; Froude JW; Gagne M; Henry AR; Mokhtari EB; Mudvari P; Krebs SJ; Pekosz AS; Currier JR; Kar S; Porto M; Winn A; Radzyminski K; Lewis MG; Vasan S; Suthar M; Polonis VR; Matyas GR; Boritz EA; Douek DC; Seder RA; Daye SP; Rao M; Peel SA; Joyce MG; Bolton DL; Michael NL; Modjarrad K
    bioRxiv; 2021 Jun; ():. PubMed ID: 34159328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drives rapid and potent immunogenicity capable of single-dose protection.
    Konrath KM; Liaw K; Wu Y; Zhu X; Walker SN; Xu Z; Schultheis K; Chokkalingam N; Chawla H; Du J; Tursi NJ; Moore A; Adolf-Bryfogle J; Purwar M; Reuschel EL; Frase D; Sullivan M; Fry B; Maricic I; Andrade VM; Iffland C; Crispin M; Broderick KE; Humeau LMPF; Patel A; Smith TRF; Pallesen J; Weiner DB; Kulp DW
    Cell Rep; 2022 Feb; 38(5):110318. PubMed ID: 35090597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge.
    Xia M; López K; Vago FS; Huang P; Auguste DI; Jiang W; Auguste AJ; Tan M
    Biotechnol J; 2023 Oct; 18(10):e2300130. PubMed ID: 37300425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.
    García-Arriaza J; Garaigorta U; Pérez P; Lázaro-Frías A; Zamora C; Gastaminza P; Del Fresno C; Casasnovas JM; Sorzano CÓS; Sancho D; Esteban M
    J Virol; 2021 Mar; 95(7):. PubMed ID: 33414159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice.
    Powell AE; Zhang K; Sanyal M; Tang S; Weidenbacher PA; Li S; Pham TD; Pak JE; Chiu W; Kim PS
    ACS Cent Sci; 2021 Jan; 7(1):183-199. PubMed ID: 33527087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice.
    Powell AE; Zhang K; Sanyal M; Tang S; Weidenbacher PA; Li S; Pham TD; Pak JE; Chiu W; Kim PS
    bioRxiv; 2020 Aug; ():. PubMed ID: 32869030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice.
    Lee KS; Rader NA; Miller-Stump OA; Cooper M; Wong TY; Shahrier Amin M; Barbier M; Bevere JR; Ernst RK; Heath Damron F
    Vaccine; 2023 Jul; 41(34):5003-5017. PubMed ID: 37407405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies.
    Shrivastava S; Carmen JM; Lu Z; Basu S; Sankhala RS; Chen WH; Nguyen P; Chang WC; King J; Corbitt C; Mayer S; Bolton JS; Anderson A; Swafford I; Terriquez GD; Trinh HV; Kim J; Jobe O; Paquin-Proulx D; Matyas GR; Gromowski GD; Currier JR; Bergmann-Leitner E; Modjarrad K; Michael NL; Joyce MG; Malloy AMW; Rao M
    NPJ Vaccines; 2023 Mar; 8(1):43. PubMed ID: 36934088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses.
    Carnell GW; Ciazynska KA; Wells DA; Xiong X; Aguinam ET; McLaughlin SH; Mallery D; Ebrahimi S; Ceron-Gutierrez L; Asbach B; Einhauser S; Wagner R; James LC; Doffinger R; Heeney JL; Briggs JAG
    J Virol; 2021 Jul; 95(15):e0020321. PubMed ID: 33963055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic Mice.
    Wong TY; Horspool AM; Russ BP; Ye C; Lee KS; Winters MT; Bevere JR; Miller OA; Rader NA; Cooper M; Kieffer T; Sourimant J; Greninger AL; Plemper RK; Denvir J; Cyphert HA; Barbier M; Torrelles JB; Martinez I; Martinez-Sobrido L; Damron FH
    J Virol; 2022 Mar; 96(6):e0218421. PubMed ID: 35080423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses.
    Ma X; Zou F; Yu F; Li R; Yuan Y; Zhang Y; Zhang X; Deng J; Chen T; Song Z; Qiao Y; Zhan Y; Liu J; Zhang J; Zhang X; Peng Z; Li Y; Lin Y; Liang L; Wang G; Chen Y; Chen Q; Pan T; He X; Zhang H
    Immunity; 2020 Dec; 53(6):1315-1330.e9. PubMed ID: 33275896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
    Pérez P; Astorgano D; Albericio G; Flores S; Sánchez-Cordón PJ; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2022; 13():995235. PubMed ID: 36172368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection.
    Pérez P; Lázaro-Frías A; Zamora C; Sánchez-Cordón PJ; Astorgano D; Luczkowiak J; Delgado R; Casasnovas JM; Esteban M; García-Arriaza J
    Front Immunol; 2021; 12():824728. PubMed ID: 35154086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.